Location: Home > Pharma China Web Edition
  • search
  • go
  • Other News
    Upcoming event: ACCESS India & China 11/4/2008

    Event: IBC’s 3rd International Conference: ACCESS India & China
    Dates: February 9-10, 2009
    Venue: Sheraton Hotel & Marina, in San Diego, California
    Weblink: www.IBCLifeSciences.com/ACCESS
    Contact: sgarofalo@ibcusa.com

    IBC Life Sciences announces that the ACCESS India & China international conference will take place at the Sheraton Hotel & Marina, in San Diego, California on February 9-10, 2009. 

    As the Asia partnering landscape is rapidly changing, ACCESS India & China helps to uncover not just the capabilities of Asian partners, but also any potential gaps in preclinical sourcing and inventory resources, along with techniques to overcome them. Formerly titled "Biology, Preclinical and Beyond in India and China", this year’s conference focuses on examples of partnerships where companies were able to combine resources, increase capacity, gain speed and find new ideas.  

    Key Themes include:

    * Leveraging Integrated Biology and Chemistry Services in China and India to Speed up Drug Discovery and Development

    * Scientific and Technological Innovations to Alleviate Bottlenecks in the R&D Pipeline

    * Growing Capabilities of Academic Research Centers and Successfully Tapping Lucrative Therapeutic Area Research

    * Unraveling Regulatory Challenges and Protecting Intellectual Property in Asia to Enable Solid Infrastructure Growth

    Conference speakers will discuss successful discovery and development collaborations, future expectations for the industry and dos and don'ts for succeeding in high value partnerships in India and China. Debbie Hartman, Ph.D., VP Lead Generation Discovery Enabling Capabilities Sciences (DECS), Astra Zeneca will present the AstraZeneca-Wuxi Pharmatech case study followed by a Pfizer case study from Martin Edwards, VP & Head of Discovery Chemistry Global R&D La Jolla Laboratories Pfizer. In addition, attendees will have the chance to hear Eli Lilly & Company and Novartis Pharmaceuticals give presentations at the conference.

    Also featured are two panel sessions, The CRO Renaissance and Bridging East and West: Licensing & Partnering Trends across the Pacific.  Both will facilitate discussion on the expansion and recent changes of the pharmaceutical marketplace in China and India and how this impacts multinational pharmaceutical and biotech companies.

    For up-to-date information and to register for this event, visit www.IBCLifeSciences.com/ACCESS.

    To apply for a press pass, please contact sgarofalo@ibcusa.com.

    About IBC Life Sciences

    IBC Life Sciences is the worldwide leader in scientific, technological and business conferences and courses for the life science industry.  To develop its programs, IBC actively researches the advancements, technologies and trends impacting and driving the race for new drugs and therapies.  No other organization can make claim to the breadth and quality that IBC Life Sciences delivers in each event giving the company recognition around the globe for quality, service and value.  For more information, visit: http://www.IBCLifeSciences.com.

  • Site map | Contact Us | Links
  • © Wicon International Group